PubMed:27277809 / 440-560 JSONTXT

{"project":"Inflammaging","denotations":[{"id":"T4","span":{"begin":0,"end":120},"obj":"Sentence"},{"id":"T4","span":{"begin":0,"end":120},"obj":"Sentence"}],"text":"Tecfidera, a putative Nrf2 activator, is an oral formulation of dimethylfumarate (DMF) used to treat multiple sclerosis."}